Novan, Inc. (NOVN) financial statements (2021 and earlier)

Company profile

Business Address 4105 HOPSON ROAD
MORRISVILLE, NC 27560
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments148335
Cash and cash equivalents148335
Deferred costs000 
Other undisclosed current assets2111
Total current assets:169436
Noncurrent Assets
Operating lease, right-of-use asset2
Property, plant and equipment11161716
Intangible assets, net (including goodwill)0000
Intangible assets, net (excluding goodwill)0000
Restricted cash and investments1111
Other noncurrent assets010 
Total noncurrent assets:13171717
TOTAL ASSETS:29262152
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3458
Accounts payable2103
Accrued liabilities1122
Employee-related liabilities0122
Deferred revenue4
Debt1000
Deferred revenue and credits2 
Contract with customer, liability4
Other undisclosed current liabilities4116
Total current liabilities:139813
Noncurrent Liabilities
Long-term debt and lease obligation5000
Capital lease obligations000
Operating lease, liability5
Liabilities, other than long-term debt947 
Deferred revenue and credits7 
Deferred revenue7
Contract with customer, liability3
Other liabilities10  
Derivative instruments and hedges, liabilities21  
Other undisclosed noncurrent liabilities26888
Total noncurrent liabilities:4012158
Total liabilities:53212321
Stockholders' equity
Stockholders' equity attributable to parent(24)5(2)31
Common stock0000
Treasury stock, value(0)(0)(0)(0)
Additional paid in capital180178158154
Accumulated deficit(204)(172)(160)(123)
Total stockholders' equity:(24)5(2)31
TOTAL LIABILITIES AND EQUITY:29262152

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Gross profit:562 
Operating expenses(36)(35)(38)(60)
Operating loss:(31)(29)(36)(60)
Nonoperating income (expense)016(1)0
Investment income, nonoperating   0
Other nonoperating income00 0
Interest and debt expense(0)(1) (0)
Net loss:(31)(14)(37)(60)
Other undisclosed net income attributable to parent01 0
Net loss available to common stockholders, diluted:(31)(13)(37)(60)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(31)(14)(37)(60)
Comprehensive loss:(31)(14)(37)(60)
Other undisclosed comprehensive income, net of tax, attributable to parent01  
Comprehensive loss, net of tax, attributable to parent:(31)(13)(37)(60)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: